Wiley.com
Print this page Share

Media Toolkit

Contact the Publicist

Contact Publicity to:

  • Request an Interview
  • Request a Review Copy
More Press Releases in: Engineering, Medicine & Healthcare
July 02, 2015

Wiley and the British Society for Nanomedicine partner on a new open access journal

Hoboken, NJ – July 2, 2015 - John Wiley and Sons, Inc., and the British Society for Nanomedicine announced today the launch of a new open access publication, the Journal of Interdisciplinary Nanomedicine.

The Journal of Interdisciplinary Nanomedicine (JOIN) is an international, peer-reviewed journal that aims to provide truly interdisciplinary nanomedicine research. JOIN will contain evidence-based outputs with high-level contributions from at least two sciences and embraces submissions from all relevant fields.

The journal joins Wiley’s portfolio of nanotechnology journals with the support of many respected titles, including: Advanced Materials, Advanced Functional Materials, Advanced Healthcare Materials, Macromolecular Bioscience, and Small. JOIN is one of the first open access journals to offer interdisciplinary research specific to nanomedicine.

“The research published here will impact the future of healthcare and nanotechnology,” said Rachel Burley, Vice President and Director of Open Access at Wiley. “Wiley is excited to partner with the British Society for Nanomedicine to publish groundbreaking research in this important area.”

“Nanomedicine is implicitly interdisciplinary and cannot progress through to meaningful patient benefits without effective collaborations drawing on a wide range of science areas. The British Society for Nanomedicine is delighted to be working with Wiley to provide a new journal which that aims to deliver our shared vision of providing a vehicle that fully reviews and recognizes the input from multiple disciplines” said Andrew Owen, a co-editor-in-chief for JOIN and a Professor of Pharmacology at the University of Liverpool.

Andrew Owen is also Chair of the British Society for Nanomedicine and a fellow of the Society of Biology. Andrew's recent research focuses on addressing translational barriers for various nanotechnologies being applied to treatment of infectious diseases. The journal has been co-founded with Professor Steve Rannard (University of Liverpool, UK), Professor Si-Shen Feng (National University of Singapore, Singapore and The Second Military Medical University, China) and Dr Raj Bawa (Rensselaer Polytechnic Institute, Troy, New York and Bawa Biotech LLC, Ashburn, VA).

All articles in JOIN will be published under the Creative Commons Attribution (CC-BY) License on Wiley Online Library. Authors with open access mandates from funders will be fully compliant when publishing with this journal. A publication fee will be payable by authors on acceptance of their articles. Authors affiliated with, or funded by, an organization that has a Wiley Open Access Account can publish without directly paying any publication charges.

The journal is open to submissions now and plans to publish the first issue online in Fall 2015. For more information, visit www.JOINjournal.com.


For media enquiries relating to the British Society for Nanomedicine, please contact: Nuala Keegan, Secretary to the British Society for Nanomedicine: [email protected]. www.britishsocietynanomedicine.org.


About the British Society for Nanomedicine
The British Society for Nanomedicine is a registered charity created to allow open access for industry, academia, clinicians and the public to news and information about research throughout the UK and around the world. The Society’s mission includes the direct explanation of the ongoing science and commercial developments to allow the public to understand and stay in touch with nanomedicine as it impacts future global healthcare. The Society is affiliated to other leading organisations involved with nanomedicine including: CLINAM, the European Technology Platform for Nanomedicine, the British Pharmacological Society and the American Society for Nanomedicine.

About Wiley
Wiley is a global provider of knowledge and knowledge-enabled services that improve outcomes in areas of research, professional practice and education. Through the Research segment, the Company provides digital and print scientific, technical, medical, and scholarly journals, reference works, books, database services, and advertising. The Professional Development segment provides digital and print books, online assessment and training services, and test prep and certification. In Education, Wiley provides education solutions including online program management services for higher education institutions and course management tools for instructors and students, as well as print and digital content.